CLINICAL_TRIALS
trial_result
· 2022-04-04
Clinical Trial Update: Efficacy and Safety of Botulinum Toxin at Moderate to Severe Glabellar Lines [Phase 3]
Summary
Phase 3 trial update on the efficacy and safety of botulinum toxin for moderate to severe glabellar lines has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: EuBiologics Co.,Ltd | Conditions: Glabellar Frown Lines | Phase 3 | Status: COMPLETED